- Home
- SXTC vs TPST Comparison
SXTC vs TPST Comparison
Compare SXTC & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- TPST
- Stock Information
- Founded
- SXTC 2005
- TPST 2011
- Country
- SXTC China
- TPST United States
- Employees
- SXTC N/A
- TPST N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- SXTC Health Care
- TPST Health Care
- Exchange
- SXTC Nasdaq
- TPST Nasdaq
- Market Cap
- SXTC 25.5M
- TPST 24.5M
- IPO Year
- SXTC 2019
- TPST N/A
- Fundamental
- Price
- SXTC $1.32
- TPST $6.70
- Analyst Decision
- SXTC
- TPST Hold
- Analyst Count
- SXTC 0
- TPST 3
- Target Price
- SXTC N/A
- TPST $30.00
- AVG Volume (30 Days)
- SXTC 2.4M
- TPST 39.8K
- Earning Date
- SXTC 01-01-0001
- TPST 05-13-2025
- Dividend Yield
- SXTC N/A
- TPST N/A
- EPS Growth
- SXTC N/A
- TPST N/A
- EPS
- SXTC 20.77
- TPST N/A
- Revenue
- SXTC $1,818,404.00
- TPST N/A
- Revenue This Year
- SXTC N/A
- TPST N/A
- Revenue Next Year
- SXTC N/A
- TPST N/A
- P/E Ratio
- SXTC $0.07
- TPST N/A
- Revenue Growth
- SXTC 6.78
- TPST N/A
- 52 Week Low
- SXTC $0.95
- TPST $5.35
- 52 Week High
- SXTC $11.92
- TPST $44.59
- Technical
- Relative Strength Index (RSI)
- SXTC 41.43
- TPST 48.61
- Support Level
- SXTC $1.34
- TPST $5.92
- Resistance Level
- SXTC $1.76
- TPST $6.44
- Average True Range (ATR)
- SXTC 0.23
- TPST 0.38
- MACD
- SXTC -0.01
- TPST 0.06
- Stochastic Oscillator
- SXTC 15.71
- TPST 71.56
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.